Global Biotech Wins Queen’s Award for Enterprise
Biocatalysts, a global biotechnology company, has announced it has been named as one of the winners of the Queen’s Awards for Enterprise in Innovation.
In an April 23, 2019 press release, Biocatalysts, a global biotechnology company, has announced it has been named as one of the winners of the Queen’s Awards for Enterprise in Innovation.
The Queen’s Awards for Enterprise are announced annually and are granted to United Kingdom businesses deemed to have demonstrated ‘outstanding achievement’ in the fields of innovation, international trade, sustainable development, and promoting opportunity through social mobility.
Biocatalysts has been granted an award in recognition of its approach to providing enzyme solutions to its customers. Specifically, the company has been recognized for its MetXtra bespoke software system, which is capable of screening millions of sequences to identify new enzymes in hours.
Rod Sears-Black, Biocatalysts’ managing director, commented in the release, “We are very proud to receive the Queen’s award for Innovation. It recognizes the dedication and commitment of the Biocatalysts team to create this unique offering to the market.”
Source: Biocatalysts
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
